secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
CIK:        0001823239
Form:       8-K
Filed at:   2026-02-25T23:59:59+00:00
Accession:  0001823239-26-000005
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Maravai Q4 revenue $49.9M, net loss $63M; guides 2026 revenue $200-210M
-----------------------------------------------------------------------

- Q4 revenue $49.9M, net loss $(63.0)M, positive Adj EBITDA $0.5M (non-GAAP).
- Full year 2025 revenue $185.7M, net loss $(230.8)M, Adj EBITDA $(31.2)M.
- Introduces 2026 revenue guidance $200M-$210M and Adj EBITDA guidance $18M-$20M.
- CEO cites strong execution, exceeding revenue expectations, returning to positive Adj EBITDA.
- Organizational restructuring and operating cost reduction ahead of plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1823239/000182323926000005/0001823239-26-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1823239/000182323926000005/mrvi-20260225.htm
  HTML page:      https://secwatch.observer/filing/0001823239-26-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer